Navigation Links
DaVita Strives to Improve Quality of Life and Reduce Overall Costs of Kidney Care Through Community-Based Education
Date:6/23/2008

EL SEGUNDO, Calif., June 23 /PRNewswire/ -- DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney failure and disease (CKD), recently introduced its EMPOWER program, a series of free community-based workshops that encourage CKD patients to take control of their health and make informed decisions about their dialysis care.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

Available in more than 40 locations throughout the U.S. and led by a team of DaVita(R) nurses, renal dietitians and social workers, EMPOWER uses a multidisciplinary approach to educate CKD patients about their disease, delaying its progression and the different treatment options available. Workshops also focus on preparing patients for life on dialysis, or a kidney transplant if needed.

The program's goal is to impact the lives of the more than eight million Americans living with Stage 3 and 4 CKD. To date, DaVita has also reached out to more than 100,000 Americans through its Kidney Education and You(R) program, which offers health education seminars and useful tools to help prevent kidney disease brought on by risk factors like diabetes and high blood pressure.

"Education is one of the most powerful ways to help people with CKD," says Dori Schatell, MS, executive director of the non-profit Medical Education Institute. "Two different research groups have found that education is even more effective than nephrologist referral at slowing the progression of CKD, ensuring a planned (rather than emergent) dialysis start and even improving survival. The more opportunities patients have to learn about kidney disease, the better they can care for themselves -- and make treatment choices that will fit their lives and enable them to keep their jobs or continue other activities that are meaningful to them."

Workshops are stage-specific, focusing on the unique needs of early stage and late stage CKD patients. Early stage CKD patients learn about how the kidneys function, how to take control of kidney disease and what to expect should the kidneys fail. Late stage CKD patients, those most at risk for kidney failure, learn how to adjust to life on dialysis by controlling their diet, taking the proper medications and choosing the best treatment for their lifestyle. EMPOWER workshops are also open to friends and family members of kidney patients, and encourage their participation.

"Our approach to shaping the future of kidney care is to no longer be just a 'dialysis company', but a kidney care community that strives to make a difference in the lives of all kidney patients," says Kent Thiry, DaVita chairman and CEO. "DaVita believes that by dedicating resources to the full continuum of kidney disease and nephrology practice needs, these efforts will begin to reduce the overall burden on our national healthcare system's limited resource pool."

For more information about the EMPOWER program, including a schedule of upcoming workshops and locations, please call 1-888-MyKidney. DaVita also offers a wide-range of tools designed to help CKD patients manage their dietary and nutritional needs through its user-friendly Web site at http://www.davita.com.

DaVita and Kidney Education and You are registered trademarks of DaVita Inc. All other trademarks are the property of their respective owners.

About DaVita Inc.

DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita manages more than 1,300 outpatient facilities and acute units in more than 700 hospitals located in 43 states and the District of Columbia, serving approximately 107,000 patients. As part of DaVita's commitment to building a healthy, caring community, DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment. For more information about DaVita, its kidney education and its community programs, please visit http://www.davita.com.


'/>"/>
SOURCE DaVita Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. DaVita Clinical Research Completes Record Number of Renal Trials in 2007
2. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
3. Kansas Invests Millions in Innovations to Improve Human Health and Launches Three National Bioscience Programs at BIO08
4. Novel Testosterone Gel Significantly Improves Insulin Sensitivity and Sexual Function in Hypogonadal Men With Type 2 Diabetes and Metabolic Syndrome
5. Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis
6. Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis
7. Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder
8. After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008
9. CherryPharm First All-Natural Food to Improve Sleep
10. Abbotts Phase III Sub-Group Analysis Shows Investigational TriLipix(TM) in Combination with CRESTOR(R) Improves Key Lipids in Patients with Mixed Dyslipidemia and Type 2 Diabetes
11. Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... 2017  True Health, a leader in integrated ... during National Breast Cancer Awareness month to educate ... Research recently published ... more than 10 million American women are at ... or BRCA2 and have not had testing. These mutations ...
(Date:10/10/2017)...   West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today shared the results of a study highlighting ... intradermal administration of polio vaccines. The study results were ... 2017 by Dr. Ondrej Mach , Clinical Trials ... (WHO), and recently published in the journal Vaccine. ...
(Date:10/4/2017)... Korea , Oct. 4, 2017  South Korean-based ... next-generation CPR training aide "cprCUBE" on Kickstarter. The device ... compression during cardiac arrests with better efficiency compared to ... also offers real-time feedback on efficacy of the compression ... crowdfunding campaign has a goal to raise $5,000. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed ... geared towards children of all ages; it is a non-competitive, non-timed event, which is ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “America On The ... identity. “America On The Brink” is the creation of published author, William Nowers. ... great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... ... 2017 , ... In the United States, single-family home owners ... New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the average is $7,000 ... property-tax rates, which contributes to the relatively lower cost of living in places ...
Breaking Medicine News(10 mins):